Skip to main content

Impact of delayed fixation and decalcification on PD-L1 expression: a comparison of two clones.

Forest F, Cote G, Laville D, Da Cruz V, Péoc'h M, Camy F, Mobarki M, Clemenson A, Yvorel V, Dal Col P

Publication: Virchows Arch (2019) • Vol 475 • Page 693-699PMID: 31267202View on PubMed

Purpose

This paper investigated the effects of decalcification agent (DC3 Qpath or the MicroDec EDTA-based decalcifier) and duration (4 h up to 3 days), and a delay to fixation (cold ischemia time) of up to 25 h on the PD-L1 immunostaining (staining intensity and the percentage of PD-L1 positive cells) as assessed by immunohistochemistry (IHC) using two different PD-L1 antibodies. A combination of placental and PD-L1-positive lung tumor specimens was used.

Conclusion

Overall, decalcification with DC3 resulted in a significant decrease in the percentage of PD-L1 22C3 stained cells and PD-L1 22C3 staining intensity that were dependent on the duration of decalcification; decalcification with EDTA resulted in less severe losses in 22C3 staining. Compared to non-decalcified control specimens, specimens decalcified in DC3 for 4 h had a significantly lower percentage of PD-L1 22C3 stained cells (approximately 25% fewer, P=0.038) and those decalcified for 8 h had a significant reduction in PD-L1 22C3 immunostaining intensity (P=0.033). When specimens were decalcified in EDTA, decalcification for 48 h led to a significant decline in the percentage of PD-L1 22C3 stained cells (P=0.006) and specimens decalcified for ≥ 20 h had a significant reduction in PD-L1 22C3 staining intensity (P=0.048). The effects of decalcification on PDL1 EIL3N antibody staining were less pronounced than the effects on PD-L1 22C3 staining, with no significant effects observed when decalcification was for ≤ 24 h or in EDTA-decalcified specimens regardless of duration.  However, PD-L1 staining with EIL3N was significantly affected when specimens were decalcified in DC3 for ≥ 1 day, resulting in a significant reduction in staining intensity (P=0.008), or for ≥3 days, which reduced the percentage of immunopositive cells (P=0.020).

The percentage of PD-L1 positive cells and PD-L1 staining intensity were unaffected by delays to fixation that were ≤ 24 h, regardless of the antibody used.

Studies (2)

Purpose

This study compared the PD-L1 immunohistochemical staining of placental and lung tumor specimens decalcified with DC3 Qpath or the MicroDec EDTA-based decalcifier for 4 h to 3 days with staining in case-matched undecalcified specimens. Potential effects of decalcification agent and duration were assessed by immunohistochemistry (IHC) using two different PD-L1 antibodies.  Seven normal placenta and five PD-L1-positive surgically resected lung cancer specimens (2 adenocarcinomas, 2 pleomorphic carcinomas, 1 squamous cell carcinoma) were obtained and immediately cut into pieces with a cross sectional area of 4-8 mm2. To investigate the effect of decalcification method and duration, case-matched pieces of six placental tissues and two lung pleomorphic carcinoma specimens were fixed in 4% buffered formaldehyde for 24 h at room temperature, then decalcified in the DC3 Qpath or MicroDec EDTA-based decalcifier for 4, 8, 12, 16, 20 and 24 h. To investigate the effect of prolonged decalcification with DC3 or EDTA-based decalcifier, case-matched pieces of five placental tissues and four lung cancers (2 adenocarcinomas, 1 squamous cell carcinoma, and 1 pleomorphic carcinoma) were fixed in formalin (details not specified) for 24-72 h at room temperature, then were   decalcified in DC3 Qpath or the MicroDec EDTA-based decalcifier for 1, 3 and 5 days. After decalcification, specimens were rinsed with water, placed in formalin for < 24 h and embedded in paraffin. Sections (4 μm thick) were immunohistochemically stained with two different antibodies against PD-L1 (clones 22C3 and E1L3N) and were scored based on the percentage of immunopositively stained cells. Staining intensity was classified as 0 (no staining), 1 (weak intensity), 2 (moderate intensity), and 3 (strong intensity).

Summary of Findings

Overall, decalcification with DC3 resulted in a significant decrease in the percentage of PD-L1 22C3 stained cells and PD-L1 22C3 staining intensity that were dependent on the duration of decalcification; decalcification with EDTA resulted in less severe losses in 22C3 staining. Compared to non-decalcified control specimens, specimens decalcified in DC3 for 4 h had a significantly lower percentage of PD-L1 22C3 stained cells (approximately 25% fewer, P=0.038) and those decalcified for 8 h had a significant reduction in PD-L1 22C3 immunostaining intensity (P=0.033). When specimens were decalcified in EDTA, decalcification for 48 h led to a significant decline in the percentage of PD-L1 22C3 stained cells (P=0.006) and specimens decalcified for ≥ 20 h had a significant reduction in PD-L1 22C3 staining intensity (P=0.048). The effects of decalcification on PDL1 EIL3N antibody staining were less pronounced than the effects on PD-L1 22C3 staining, with no significant effects observed when decalcification was for ≤ 24 h or in EDTA-decalcified specimens regardless of duration.  However, PD-L1 staining with EIL3N was significantly affected when specimens were decalcified in DC3 for ≥ 1 day, resulting in a significant reduction in staining intensity (P=0.008), or for ≥3 days, which reduced the percentage of immunopositive cells (P=0.020).

  • Biospecimens

    TissuePlacenta
    TissueLung
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
    Pregnant
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Analyte Extraction and PurificationDecalcification solution/ duration
    0, 1, 2 or 3 days
    0, 4, 8, 12, 16 , 20 or 24 h
    DC3
    EDTA
    Immunohistochemistry SpecificType of antibody
    PD-L1 22C3
    PD-L1 EIL3N